FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and can be used to reduce the content of apolipoprotein C-III (apoC-III) mRNA or protein in a subject in need thereof. That is ensured by administering a pharmaceutically effective amount of compound representing 2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanoic acid or its pharmaceutically acceptable salt. Also disclosed is use of said compound for preparing a medicinal agent.
EFFECT: group of invention provides effective reduction of the content of apolipoprotein C-III (apoC-III) mRNA or protein in a subject in need thereof.
50 cl, 1 dwg, 2 tbl, 25 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STRUCTURALLY ENHANCED OXYGEN-CONTAINING FATTY ACIDS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS | 2018 |
|
RU2820995C2 |
| CONJUGATES OF FATTY ACIDS AND NIACIN AND APPLICATION THEREOF | 2010 |
|
RU2569063C2 |
| COMPOSITIONS AND METHODS OF TREATMENT OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2751770C2 |
| FATTY ACID FUMARATE DERIVATIVES AND USES THEREOF | 2011 |
|
RU2588256C2 |
| ALPHA-SUBSTITUTED OMEGA-3 LIPIDS, ACTIVATORS OR MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR (PPAR) | 2007 |
|
RU2507193C2 |
| CONJUGATED LIPID DERIVATIVES | 2007 |
|
RU2480447C2 |
| NOVEL LIPID COMPOUNDS | 2007 |
|
RU2509071C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF GASTROINTESTINAL POLYPS | 2017 |
|
RU2749188C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF XEROSTOMIA | 2017 |
|
RU2749189C2 |
| 15-HYDROXY-5Z,8Z,11Z,13E-EICOZATETRAENIC ACID MULTIPLE LABELED WITH TRITIUM AT DOUBLE BONDS AND METHOD OF ITS SYNTHESIS | 1993 |
|
RU2073665C1 |
